Cargando…

Unveiling the Potentiality of Shikonin Derivatives Inhibiting SARS-CoV-2 Main Protease by Molecular Dynamic Simulation Studies

Shikonin, a phytochemical present in the roots of Lithospermum erythrorhizon, is well-known for its broad-spectrum activity against cancer, oxidative stress, inflammation, viruses, and anti-COVID-19 agents. A recent report based on a crystallographic study revealed a distinct conformation of shikoni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Das, Raju, Habiba, Sarmin Ummey, Dash, Raju, Seo, Yohan, Woo, Joohan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963214/ https://www.ncbi.nlm.nih.gov/pubmed/36834524 http://dx.doi.org/10.3390/ijms24043100

Ejemplares similares

Brain modulation by the gut microbiota: From disease to therapy
por: Mitra, Sarmistha, et al.
Publicado: (2022)

Unveiling the Effect of Low pH on the SARS-CoV-2 Main Protease by Molecular Dynamics Simulations
por: Barazorda-Ccahuana, Haruna Luz, et al.
Publicado: (2021)

Unveiling mutation effects on the structural dynamics of the main protease from SARS-CoV-2 with hybrid simulation methods
por: Gasparini, P., et al.
Publicado: (2023)

Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors
por: Ma, Chunlong, et al.
Publicado: (2020)

Ebselen, disulfiram, carmofur, PX-12, tideglusib, and shikonin are non-specific promiscuous SARS-CoV-2 main protease inhibitors
por: Ma, Chunlong, et al.
Publicado: (2020)

Structural Consequence of Non-Synonymous Single-Nucleotide Variants in the N-Terminal Domain of LIS1
por: Choi, Ho Jin, et al.
Publicado: (2022)

Crystal structure of SARS-CoV-2 main protease in complex with the natural product inhibitor shikonin illuminates a unique binding mode
por: Li, Jian, et al.
Publicado: (2021)

Inhibition Mechanism of SARS‐CoV‐2 Main Protease with Ketone‐Based Inhibitors Unveiled by Multiscale Simulations: Insights for Improved Designs
por: Ramos‐Guzmán, Carlos A., et al.
Publicado: (2021)

Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors
por: Cardoso, Wesley B., et al.
Publicado: (2021)

Design, synthesis and docking study of Vortioxetine derivatives as a SARS-CoV-2 main protease inhibitor
por: Suryavanshi, Hemant, et al.
Publicado: (2022)

Supercomputer simulation of the covalent inhibition of the main protease of SARS-CoV-2
por: Nemukhin, A. V., et al.
Publicado: (2022)

Molecular docking and dynamics simulation of main protease of SARS-CoV-2 with naproxen derivative
por: K Hussein, Rageh, et al.
Publicado: (2023)

Benchmarking the ability of novel compounds to inhibit SARS-CoV-2 main protease using steered molecular dynamics simulations
por: Singh, Rahul, et al.
Publicado: (2022)

Drug binding dynamics of the dimeric SARS-CoV-2 main protease, determined by molecular dynamics simulation
por: Komatsu, Teruhisa S., et al.
Publicado: (2020)

Dynamics of the SARS-CoV-2 main protease binding site
por: Harith, Advaith S., et al.
Publicado: (2023)

Activation and maturation of SARS-CoV main protease
por: Xia, Bin, et al.
Publicado: (2011)

Design of SARS-CoV-2 Main Protease Inhibitors Using Artificial Intelligence and Molecular Dynamic Simulations
por: Elend, Lars, et al.
Publicado: (2022)

Potent and biostable inhibitors of the main protease of SARS-CoV-2
por: Tsuji, Kohei, et al.
Publicado: (2022)

Hunting the main protease of SARS-CoV-2 by plitidepsin: Molecular docking and temperature-dependent molecular dynamics simulations
por: Vishvakarma, Vijay Kumar, et al.
Publicado: (2021)

Unveiling the Inhibitory Potentials of Peptidomimetic Azanitriles and Pyridyl Esters towards SARS-CoV-2 Main Protease: A Molecular Modelling Investigation
por: Mushebenge, Aganze G., et al.
Publicado: (2023)

The SARS-CoV-2 main protease as drug target
por: Ullrich, Sven, et al.
Publicado: (2020)

Topological analysis of SARS CoV-2 main protease
por: Estrada, Ernesto
Publicado: (2020)

Potential SARS-CoV-2 main protease inhibitors
por: Banerjee, Riddhidev, et al.
Publicado: (2021)

Developing inhibitors of the SARS-CoV-2 main protease
por: Seitz, Christian, et al.
Publicado: (2022)

Allosteric Hotspots in the Main Protease of SARS-CoV-2
por: Strömich, Léonie, et al.
Publicado: (2022)

Allosteric inhibitors of the main protease of SARS-CoV-2
por: Samrat, Subodh Kumar, et al.
Publicado: (2022)

Impact of Drug Repurposing on SARS-Cov-2 Main Protease
por: Ndagi, Umar, et al.
Publicado: (2023)

Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design
por: Yu, Wei, et al.
Publicado: (2021)

Identification of Food Compounds as inhibitors of SARS-CoV-2 main protease using molecular docking and molecular dynamics simulations
por: Masand, Vijay H., et al.
Publicado: (2021)

Allosteric Modulation of the Main Protease (M(Pro)) of SARS-CoV-2 by Casticin—Insights from Molecular Dynamics Simulations
por: Mensah, Jehoshaphat Oppong, et al.
Publicado: (2022)

Molecular Dynamics Simulation of Ligands from Anredera cordifolia (Binahong) to the Main Protease (M(pro)) of SARS-CoV-2
por: Fatriansyah, Jaka Fajar, et al.
Publicado: (2022)

In silico analyses of major active constituents of fingerroot (Boesenbergia rotunda) unveils inhibitory activities against SARS-CoV-2 main protease enzyme
por: Bahadur Gurung, Arun, et al.
Publicado: (2022)

Unveiling the molecular mechanism of SARS-CoV-2 main protease inhibition from 137 crystal structures using algebraic topology and deep learning
por: Nguyen, Duc Duy, et al.
Publicado: (2020)

In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease
por: Ram, Thrigulla Saketh, et al.
Publicado: (2022)

Computational analysis of dynamic allostery and control in the SARS-CoV-2 main protease
por: Dubanevics, Igors, et al.
Publicado: (2021)

Rapid prediction of possible inhibitors for SARS-CoV-2 main protease using docking and FPL simulations
por: Pham, Minh Quan, et al.
Publicado: (2020)

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
por: Mahdi, Mohamed, et al.
Publicado: (2020)

Biochemical screening for SARS-CoV-2 main protease inhibitors
por: Coelho, Camila, et al.
Publicado: (2020)

Structure of SARS-CoV-2 main protease in the apo state
por: Zhou, Xuelan, et al.
Publicado: (2020)

Correlation between dissociation and catalysis of SARS-CoV main protease
por: Lin, Pei-Ying, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_msre4i5l3738vkrrtlkuudolbs